Regenio

Regenio is a Swiss biotechnology company specializing in regenerative medicine through autologous cell therapies. The company develops and commercializes medical devices and kits for the preparation of Platelet-Rich Plasma (PRP) and Bone Marrow Aspirate Concentrate (BMAC) at the point of care. Their products are primarily used in orthopedics, sports medicine, and wound care to accelerate tissue repair and reduce inflammation. Regenio's technology focuses on standardized, closed-system processing of a patient's own blood or bone marrow to provide high-quality biological treatments. The company is closely affiliated with Regen Lab, a global leader in the autologous regenerative medicine market. By providing clinicians with reliable tools for biological therapy, Regenio aims to improve patient outcomes in musculoskeletal health.